Chinese Drug Co. Sanctioned After 'Tortuous' 3-Year Info Fight

By Ryan Harroff · May 14, 2024, 1:09 PM EDT

Chinese drug firm Zhejiang Huahai Pharmaceutical Co. Ltd. has been hit with sanctions after its chief executive officer failed to sit for a court-ordered deposition in sprawling multidistrict litigation taking place...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019

Recent Articles By Ryan

May 10, 2024
UPMC Inks $38M Deal To End Neurosurgery FCA Suit
May 07, 2024
Hospital Says Appellate Court Flubbed $1.9M Payout Review
May 03, 2024
Ohio Statehouse Catch-Up: Trans, Abortion Laws Face Battles
April 23, 2024
Doctor Renews $20M Claim His Hospital Made Up 25 Murders
April 22, 2024
Unions Can Refile Tossed ERISA Suit Against Anthem BCBS
April 18, 2024
Would-Be Whistleblowers Drop ER Service Overbilling Claims
April 10, 2024
Insurer Slams 'Price-Gouging' Doctor's COVID Billing Suit
April 05, 2024
Ohio Families Can Bolster Bid To End Transgender Law
April 01, 2024
6th Circ. Judge Warns Of 'Trap' In Medical Malpractice Laws
March 29, 2024
8 States Seek $122M After Robocaller Allegedly Ignored Ban